Autolus Therapeutics plc — Investor Relations & Filings
Autolus Therapeutics plc is a commercial-stage biopharmaceutical company developing next-generation, programmed T cell therapies for cancer and autoimmune diseases. The company specializes in Chimeric Antigen Receptor (CAR) T-cell technology, which reprograms a patient's own T cells to recognize and eliminate disease cells. Its lead therapy, obecabtagene autoleucel (obe-cel), is approved for the treatment of adult relapsed/refractory B-cell Acute Lymphoblastic Leukemia (ALL). Autolus leverages its advanced cell programming capabilities and proprietary manufacturing processes to develop a pipeline of precise and controlled autologous therapies targeting hematological malignancies, solid tumors, and autoimmune conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2024-06-05 | English | |
| 8-K | 2024-06-03 | English | |
| 10-Q | 2024-05-17 | English | |
| 8-K | 2024-05-17 | English | |
| NT 10-Q | 2024-05-13 | English | |
| 8-K | 2024-05-13 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 13093380 | 8-K | 2024-06-05 | English | ||
| 13093381 | 8-K | 2024-06-03 | English | ||
| 13093385 | 10-Q | 2024-05-17 | English | ||
| 13093390 | 8-K | 2024-05-17 | English | ||
| 13093392 | NT 10-Q | 2024-05-13 | English | ||
| 13093395 | 8-K | 2024-05-13 | English | ||
| 13093393 | 8-K | 2024-04-01 | English | ||
| 13093394 | S-3ASR | 2024-03-28 | English | ||
| 13093396 | AMENDMENT NO. 9 TO SCHEDULE 13D | 2024-03-25 | English | ||
| 13093404 | 10-K | 2024-03-21 | English | ||
| 13093405 | 8-K | 2024-03-21 | English | ||
| 13093409 | 8-K/A | 2024-03-15 | English | ||
| 13093413 | 8-K | 2024-03-14 | English | ||
| 13093410 | Regulatory Filings 2024 | 2024-02-23 | English | ||
| 13093414 | SC 13D | 2024-02-21 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Autolus Therapeutics plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32981/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32981 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32981 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32981 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32981}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Autolus Therapeutics plc (id: 32981)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.